Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Antonia Perelló Martorell"'
Autor:
Joaquín Gavilá Gregori, Elena López Miranda, Santiago Escrivá-de-Romaní, Begoña Jiménez Rodríguez, Silvia Antolín Novoa, Luis Fernández Morales, Elena Galve Calvo, Lucía González Cortijo, Antonia Perelló Martorell, Julián Lagunar Ruiz, Santiago González Santiago
Publikováno v:
Cancer Research. 82:OT1-12
Type: Trial in progress. Introduction: Sequential intravenous (IV) treatment with pertuzumab and trastuzumab is effective in disrupting HER2 signalling in early and advanced HER2-positive breast cancer (BC). However, this strategy increases patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b900f315359d61eedd8487fedc963c19
https://doi.org/10.1158/1538-7445.sabcs21-ot1-12-09
https://doi.org/10.1158/1538-7445.sabcs21-ot1-12-09
Autor:
Isabel Calvo Plaza, Laura García-Estévez, Elena Hernández Agudo, Daniel Acosta-Eyzaguirre, Antonia Perelló Martorell
Publikováno v:
Future oncology (London, England). 14(7s)
Hepatic impairment in breast cancer arises from metastatic spread of tumor cells to the liver and signals a poor prognosis. Systemic therapy is the mainstay of treatment. Three women with hepatic dysfunction secondary to breast cancer who were treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c708c94de48c9f23c3fda7dc915ae3df
https://pubmed.ncbi.nlm.nih.gov/29611757
https://pubmed.ncbi.nlm.nih.gov/29611757
Autor:
Ciruelos, E., Vidal, M., Martínez de Dueñas, E., Martínez-Jáñez, N., Fernández, Y., García-Sáenz, J. A., Murillo, L., Carabantes, F., Beliera, A., Fonseca, R., Gavilá, J.
Publikováno v:
Clinical & Translational Oncology; Jun2018, Vol. 20 Issue 6, p753-760, 8p